| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282323 | Clinical Gastroenterology and Hepatology | 2013 | 9 Pages |
Abstract
On the basis of analysis of data from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial, higher dietary cholesterol intake is associated with higher risk of disease progression in HCV-infected patients with advanced fibrosis or compensated cirrhosis.
Keywords
AHRCTPMTPFFQTLRChild–Turcotte–PughHCCHALT-CToll-like receptorDietCirrhosisbody mass indexBMIconfidence intervaladjusted hazard ratioHepatitis CHepatitis C Antiviral Long-term Treatment against CirrhosisHepatitis C virusHCVfood frequency questionnairemicrosomal triglyceride transfer proteinHepatocellular carcinomacholesterol
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Lei Yu, Chihiro Morishima, George N. Ioannou,